From the current
development situation analysis, we can see that in the next few years in China,
and medical devices and biological medicine industry will get a great
development, it is the development of the industry of the two "feng shui
ridge".
First, because people's living standard in continuously improve, so for medical devices and medical requirements also gradually to increase, efficient, safe medical equipment and medicines for everyone is very important.
Second is the national attention and planning comes on stage in succession, has promoted the development of the industry.
Be regarded as "help medicine" human albumin, every 10 grams doses of injection prices more than $one thousand a, could be compared to gold. And this kind of "life products", it is to use biological technology from ordinary people in the plasma extracted from. And an advanced medical equipment, some tens of thousands of yuan, some large is to millions.
Traditional Chinese medicine industry "excellences"
The improvement of the medical insurance system, and further stimulate the medical needs, to speed up the development of medicine industry. In 2011, biological and pharmaceutical industry in new revenue, profit payments and tax turnover and profits three main economic indicators are higher than the national average growth, main business income was 63.174 billion yuan, up 35.38%, record levels, in the opening-up of China to the eighth. Traditional Chinese medicine industry in our province in the pharmaceutical industry is still the largest proportion of the son industry. According to the gross industrial output value calculation, in our province, proprietary Chinese medicines accounted for 7.7% of the total amount, accounting for 40.52% of the pharmaceutical industry of the whole province, implemented last year's main business income is 26.083 billion yuan, the third row.
Last year, as gas, water and electricity upstream raw material and labor costs sharply, Chinese traditional medicine the price also doubled, greatly compressed the profit space for the company. But pharmaceutical enterprise in our province through innovation, adjustment, transformation and increase domestic sales efforts, strengthen the development of new varieties, and maintain the proprietary Chinese medicine industry in the province at leading edge. At present, Chinese traditional medicine enterprises in the top 50, in our province, have five, including four household top 20. Save work committee GongYeChu medical director LiWenXin letter said: "the future proprietary Chinese medicine industry still has a great development space, Chinese traditional medicine will go abroad, some Chinese medicine enterprise to develop the field of consumer goods in traditional Chinese medicine. As a big province, has the edge."
The future, in our province, based on the rich resources of medicinal materials will be, to speed up the implementation of Chinese herbal medicine standardized production, expand the Chinese medicine yinpian production and effective component from scale, optimized production varieties, excellent product support variety of traditional Chinese medicines secondary development.
Enterprise and great variety advantages "plays"
Biological pharmaceutical is typical of capital intensive and technology-intensive industry, the development and expansion of the conditions, is one of the scale effect of the form. At the end of last year, nanchang high and new technology industry development zone biological medicine industry cluster is listed in the national innovative industry cluster pilot (foster) "object, this is our province was listed in the pilot's first industrial clusters. Nanchang high-tech zone biological medicine industry cluster mainly includes the biological medicine, biological agriculture two big industry, modern medicine, chemical medicine involved, biological agents, medical equipment, email, veterinary medicine, Chinese traditional medicine agriculture, etc. Within a cluster existing biological medicine 110 enterprises, had a twin group, is nations group, jinan people credible, jiang group and a number of backbone enterprise, has the national engineering research center, provincial key laboratory, the provincial or ministerial engineering technology research center, postdoctoral workstation and a number of research and development platform, formed a complete biological pharmaceutical scientific research, development and industrialization technology support system. With small blue biological medicine industry base, yichun medicine industry base, ZhangShuFu city medical garden, SangHai biological medicine industrial park, JinXian medical equipment industrial park, in our province last year six medicine industrial cluster with complete main business income is 26.443 billion yuan, accounting for almost the whole industry "half jiangshan".
Biological rapid development of medicine industry, cannot leave the great variety of contribute. At present, our province have six annual output value over 1 billion yuan group enterprise, single species years sales RMB one hundred million yuan of varieties increase to 19, including sales RMB 1 billion yuan of varieties have three. LiWenXin said, and the advantage of the role and large enterprise leading varieties of "breakout" in our biological medicine industry form "innovation research achievements transformation- industrialization" benign circulation laid solid foundation.
To the capital market
On March 8, jiangxi boya biological pharmaceutical Co., LTD in the shenzhen stock exchange market successfully gem. This is the first of the capital market in our province on biological pharmaceutical enterprise. The company has been engaged in blood products development, production and sales, is the national albumin, static note people immunoglobulin is one of the most complete specifications of the production enterprise, by the investors. And PuYao "battlefield" of gunpowder diffuses than the mess, biological medicine like place oneself in a quiet and far-reaching "blue ocean", but the high growth is inviting "QianJing", but it is hard to resist. No wonder even Bill Gates predicted ・ are: the next may's richest man is biological technology investors.
But, due to the biological medicine high technology, high investment, high risk, the development cycle long characteristics, at present our province biological medicine industry still has the innovation ability weak, achievements conversion low, technical level behind difficult problems. How to close the gap? LiWenXin says, in our province, biological pharmaceutical industry on one hand should jump out of the development of the application in medicine on a single path, can be expanded to the biological chemical, biological energy, biological agriculture, biological forestry, etc; On the other hand, the enterprise should learn to to the capital market "means", use of capital market, bond market and even financial derivatives, realizing the maximization of enterprise financing.
The article source-medical devices made cruel published perlong, reproduced please indicate the source
First, because people's living standard in continuously improve, so for medical devices and medical requirements also gradually to increase, efficient, safe medical equipment and medicines for everyone is very important.
Second is the national attention and planning comes on stage in succession, has promoted the development of the industry.
Be regarded as "help medicine" human albumin, every 10 grams doses of injection prices more than $one thousand a, could be compared to gold. And this kind of "life products", it is to use biological technology from ordinary people in the plasma extracted from. And an advanced medical equipment, some tens of thousands of yuan, some large is to millions.
Traditional Chinese medicine industry "excellences"
The improvement of the medical insurance system, and further stimulate the medical needs, to speed up the development of medicine industry. In 2011, biological and pharmaceutical industry in new revenue, profit payments and tax turnover and profits three main economic indicators are higher than the national average growth, main business income was 63.174 billion yuan, up 35.38%, record levels, in the opening-up of China to the eighth. Traditional Chinese medicine industry in our province in the pharmaceutical industry is still the largest proportion of the son industry. According to the gross industrial output value calculation, in our province, proprietary Chinese medicines accounted for 7.7% of the total amount, accounting for 40.52% of the pharmaceutical industry of the whole province, implemented last year's main business income is 26.083 billion yuan, the third row.
Last year, as gas, water and electricity upstream raw material and labor costs sharply, Chinese traditional medicine the price also doubled, greatly compressed the profit space for the company. But pharmaceutical enterprise in our province through innovation, adjustment, transformation and increase domestic sales efforts, strengthen the development of new varieties, and maintain the proprietary Chinese medicine industry in the province at leading edge. At present, Chinese traditional medicine enterprises in the top 50, in our province, have five, including four household top 20. Save work committee GongYeChu medical director LiWenXin letter said: "the future proprietary Chinese medicine industry still has a great development space, Chinese traditional medicine will go abroad, some Chinese medicine enterprise to develop the field of consumer goods in traditional Chinese medicine. As a big province, has the edge."
The future, in our province, based on the rich resources of medicinal materials will be, to speed up the implementation of Chinese herbal medicine standardized production, expand the Chinese medicine yinpian production and effective component from scale, optimized production varieties, excellent product support variety of traditional Chinese medicines secondary development.
Enterprise and great variety advantages "plays"
Biological pharmaceutical is typical of capital intensive and technology-intensive industry, the development and expansion of the conditions, is one of the scale effect of the form. At the end of last year, nanchang high and new technology industry development zone biological medicine industry cluster is listed in the national innovative industry cluster pilot (foster) "object, this is our province was listed in the pilot's first industrial clusters. Nanchang high-tech zone biological medicine industry cluster mainly includes the biological medicine, biological agriculture two big industry, modern medicine, chemical medicine involved, biological agents, medical equipment, email, veterinary medicine, Chinese traditional medicine agriculture, etc. Within a cluster existing biological medicine 110 enterprises, had a twin group, is nations group, jinan people credible, jiang group and a number of backbone enterprise, has the national engineering research center, provincial key laboratory, the provincial or ministerial engineering technology research center, postdoctoral workstation and a number of research and development platform, formed a complete biological pharmaceutical scientific research, development and industrialization technology support system. With small blue biological medicine industry base, yichun medicine industry base, ZhangShuFu city medical garden, SangHai biological medicine industrial park, JinXian medical equipment industrial park, in our province last year six medicine industrial cluster with complete main business income is 26.443 billion yuan, accounting for almost the whole industry "half jiangshan".
Biological rapid development of medicine industry, cannot leave the great variety of contribute. At present, our province have six annual output value over 1 billion yuan group enterprise, single species years sales RMB one hundred million yuan of varieties increase to 19, including sales RMB 1 billion yuan of varieties have three. LiWenXin said, and the advantage of the role and large enterprise leading varieties of "breakout" in our biological medicine industry form "innovation research achievements transformation- industrialization" benign circulation laid solid foundation.
To the capital market
On March 8, jiangxi boya biological pharmaceutical Co., LTD in the shenzhen stock exchange market successfully gem. This is the first of the capital market in our province on biological pharmaceutical enterprise. The company has been engaged in blood products development, production and sales, is the national albumin, static note people immunoglobulin is one of the most complete specifications of the production enterprise, by the investors. And PuYao "battlefield" of gunpowder diffuses than the mess, biological medicine like place oneself in a quiet and far-reaching "blue ocean", but the high growth is inviting "QianJing", but it is hard to resist. No wonder even Bill Gates predicted ・ are: the next may's richest man is biological technology investors.
But, due to the biological medicine high technology, high investment, high risk, the development cycle long characteristics, at present our province biological medicine industry still has the innovation ability weak, achievements conversion low, technical level behind difficult problems. How to close the gap? LiWenXin says, in our province, biological pharmaceutical industry on one hand should jump out of the development of the application in medicine on a single path, can be expanded to the biological chemical, biological energy, biological agriculture, biological forestry, etc; On the other hand, the enterprise should learn to to the capital market "means", use of capital market, bond market and even financial derivatives, realizing the maximization of enterprise financing.
The article source-medical devices made cruel published perlong, reproduced please indicate the source
没有评论:
发表评论